Related Experiment Videos
c-FLIP efficiently rescues TRAF-2-/- cells from TNF-induced apoptosis
C Guiet1, E Silvestri, E De Smaele
1Basel Institute for Immunology, Grenzacherstrasse 487, Postfach CH-4005, Basel, Switzerland.
Cell Death and Differentiation
|February 13, 2002
Summary
Tumor Necrosis Factor alpha (TNF) resistance in cells is linked to reduced levels of the anti-apoptotic molecule c-FLIP. Restoring c-FLIP levels can reverse this resistance, offering therapeutic potential.
Area of Science:
- Cellular biology
- Immunology
- Molecular mechanisms of cell death
Background:
- Tumor Necrosis Factor alpha (TNF) typically fails to induce apoptosis due to cellular resistance mechanisms.
- Cytoprotective responses are known to mediate resistance to TNF's cytotoxic activity.
Purpose of the Study:
- To investigate the molecular basis of TNF resistance in cells lacking TRAF-2.
- To determine the role of c-FLIP in mediating resistance to TNF-induced apoptosis.
Main Methods:
- Utilized TRAF-2-/- embryonic fibroblasts (EF).
- Assessed levels and degradation of the anti-apoptotic molecule c-FLIP.
- Performed reconstitution experiments by reintroducing c-FLIP into TRAF-2-/- EF.
Main Results:
- TRAF-2-/- EF exhibited significantly reduced levels of c-FLIP due to enhanced protein degradation.
- Restoring c-FLIP levels in TRAF-2-/- EF was sufficient to confer resistance to TNF toxicity.
- Confirmed the essential role of c-FLIP in cellular protection against TNF.
Conclusions:
- c-FLIP plays a critical role in protecting cells from the cytotoxic effects of TNF.
- The degradation of c-FLIP contributes to TNF resistance in TRAF-2 deficient cells.
- Findings have implications for developing treatments for inflammatory and proliferative disorders.